Clinical Benefits of a Metabolic Approach with Trimetazidine in Revascularized Patients with Angina

American Journal of Cardiology

Volumn 98, Issue 5 SUPPL. 1, 2006, Pages 8-13

  Danchin, Nicolas ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; METOPROLOL; MOLSIDOMINE; NICORANDIL; NITRATE; TRIMETAZIDINE;

ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; HEMODYNAMICS; HUMAN; POLAND; PRIORITY JOURNAL;

ANGINA PECTORIS; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 33747365277     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.003     Document Type: Article

References (22)

1. Daly C.A., Clemens F., Lopez-Sendon J.L., Tavazzi L., Boersma E., Danchin N., Delahaye F., Gitt A., Julian D., Mulcahy D., et al., Euro Heart Survey Investigators. The initial management of stable angina in Europe, from the Euro Heart Survey. a description of pharmacological management and revascularisation strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina. Eur Heart J 26 (2005) 1011-1022
2. Daly C.A., Clemens F., Lopez-Sendon J.L., Tavazzi L., Boersma E., Danchin N., Delahaye F., Gitt A., Julian D., Mulcahy D., et al., Euro Heart Survey Investigators. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe. from the Euro Heart Survey of Stable Angina. Eur Heart J 26 (2005) 996-1010
3. The EUROPA Investigators. Efficacy of perindopril on reduction of cardiovascular events among patients with stable coronary artery disease. randomised, double-blind, placebo-controlled multicentre trial (the EUROPA study). Lancet 362 (2003) 782-788
4. Poole-Wilson P.A., Lubsen J., Kirwan B.A., van Dalen F., Wagener G., Danchin N., Just H., Fox K., Pocock S., Clayton T., et al., A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial). randomised controlled trial. Lancet 364 (2004) 849-857
5. PEACE trial investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 351 (2004) 2058-2068
6. Danchin N., Dubois C., Quentzel S., and Cambou J.P. Étude Pacifique. postangioplastie coronaire en France et intervention thérapeutique. Ann Cardiol Angeiol 53 (2004) 349-356
7. Hanania G., Cambou J.P., Guéret P., Vaur L., Blanchard D., Lablanche J.-M., Boutalbi Y., Humbert R., Clerson P., Genès N., Danchin N., and USIC 2000 investigators. Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century. results from the French nationwide USIC 2000 registry. Heart 90 (2004) 1404-1410
8. Henderson R.A., Pocock S.J., Clayton T.C., Knight R., Fox K.A.A., Julian D.G., Chamberlain D.A., and Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial. coronary angioplasty versus medical treatment. J Am Coll Cardiol 42 (2003) 1161-1170
9. Pfisterer M., Buser P., Osswald S., Allemann U., Amann W., Angehrn W., Eeckhout E., Erne P., Estlinbaum W., Kuster G., et al., Trial of Invasive versus Medical therapy in Elderly patients (TIME) investigators. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy. one-year results of the randomized TIME trial. JAMA 289 (2003) 1117-1123
10. Hueb W., Soares P.R., Gersh B.J., Cesar L.A., Luz P.L., Puig L.B., Martinez E.M., Oliveira S.A., and Ramires J.A. The Medicine, Angioplasty, or Surgery trial (MASS-II): a randomized, controlled, clinical trial of three therapeutic strategies for multivessel coronary artery disease. One-year results. J Am Coll Cardiol 43 (2004) 1743-1751
11. Timour Q., Harpey C., Durr F., and Faucon G. Is the antianginal action of trimetazidine independent of hemodynamic changes?. Cardiovasc Drugs Ther 5 (1991) 1043-1044
12. Kober G., Buck T., Sievert H., and Vallbracht C. Myocardial protection during percutaneous transluminal coronary angioplasty. effects of trimetazidine. Eur Heart J 13 (1992) 1109-1115
13. Polonski L., Dec I., Wojnar R., and Wilczek K. Trimetazidine limits the effects of myocardial ischaemia during percutaneous transluminal coronary angioplasty. Curr Med Res Opin 18 (2002) 389-396
14. Labrou A., Yiannoglou G., Zioutas D., Papanastasiou S., Fragakis N., Kastaris A., and Louridas A. The role of trimetazidine at PTCA procedure. does trimetazidine minimize myocardial damage during PTCA [abstract]?. Eur Heart J 26 suppl (2005) 40 (P437)
15. Steg P.G., Laperche T., and Karila-Cohen D. Value of trimetazidine as adjuvant therapy for primary PTCA at the acute stage of myocardial infarction. Eur Heart J suppl O (1999) O19-O23
16. Fabiani J.N., Ponzio O., Emerit I., Massonet-Castel S., Paris M., Chevalier P., Jebara V., and Carpentier A. Cardioprotective effect of trimetazidine during coronary artery graft surgery. J Cardiovasc Surg 33 (1992) 486-491
17. Tünerir B., Colak O., Alatas O., Besogul Y., Kural T., and Aslan R. Measurement of troponin T to detect cardioprotective effect of trimetazidine during coronary artery bypass grafting. Ann Thorac Surg 68 (1999) 2173-2176
18. Klein W., Jackson G., and Tavazzi L. Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris. a meta-analysis. Coron Artery Dis 13 (2002) 427-443
19. Chaitman B.R., Skettino S., Parker J.O., Hanley P., Meluzin J., Kuch J., Pepine C.J., Wang W., Nelson J.J., Hebert D.A., Wolff A.A., and MARISA investigators. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 43 (2004) 1375-1382
20. Birand A., Kudaiberdieva G.Z., Batyraliev T.A., Akgul F., and Usal A. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty. Angiology 48 (1997) 413-422
21. Rużyllo W., Szwed H., Sadowski Z., Elikowski W., Grzelak-Szafranska H., Orszulak W., Szymczak K., and Winter M. Efficacy of trimetazidine in patients with recurrent angina. a subgroup analysis of the TRIMPOL II study. Curr Med Res Opin 20 (2004) 1447-1454
22. Szwed H., Sadowski Z., Elikowski W., Koronkiewicz A., Mamcarz A., Orszulak W., Skibinska E., Szymczak K., Swiatek J., and Winter M. Combination treatment in stable effort angina using trimetazidine and metoprolol. results of a randomized, double-blind, multicentre study (TRIMPOL II). Eur Heart J 22 (2001) 2267-2274